Global Large Volume Parenteral (LVP) Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Large Volume Parenteral (LVP) market size is predicted to grow from US$ 10990 million in 2025 to US$ 14670 million in 2031; it is expected to grow at a CAGR of 4.9% from 2025 to 2031.
Large volume parenteral preparations or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml, with the most common sizes being 250 ml, 500 ml, 1000 ml, 3000 ml and 5000 ml, with instructions usually recommending large volumes for administration. Parenteral preparations are sterile solid dosage forms or non-pyrogenic liquids containing one or more active ingredients in single-dose or multi-dose containers. They are intended to be administered by infusion, implant or injection into the body.
Global key players of Large Volume Parenteral (LVP) include Baxter Healthcare, Kelun Group, Fresenius, B. Braun, Ostuka Pharmaceutical, etc. The top five players hold a share about 68%. Asia-Pacific is the world's largest market for Large Volume Parenteral (LVP) and holds a share about xx%, followed by Europe and North America, with share about 25% and 24%, separately. In terms of product type, Soft Bag LVP is the largest segment, accounting for a share about 57%. In terms of application, Basic Infusion is the largest field with a share about 63 percent.
LP Information, Inc. (LPI) ' newest research report, the “Large Volume Parenteral (LVP) Industry Forecast” looks at past sales and reviews total world Large Volume Parenteral (LVP) sales in 2024, providing a comprehensive analysis by region and market sector of projected Large Volume Parenteral (LVP) sales for 2025 through 2031. With Large Volume Parenteral (LVP) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Large Volume Parenteral (LVP) industry.
This Insight Report provides a comprehensive analysis of the global Large Volume Parenteral (LVP) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Large Volume Parenteral (LVP) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Large Volume Parenteral (LVP) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Large Volume Parenteral (LVP) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Large Volume Parenteral (LVP).
This report presents a comprehensive overview, market shares, and growth opportunities of Large Volume Parenteral (LVP) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Large Volume Parenteral (LVP) market?
What factors are driving Large Volume Parenteral (LVP) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Large Volume Parenteral (LVP) market opportunities vary by end market size?
How does Large Volume Parenteral (LVP) break out by Type, by Application?
The global Large Volume Parenteral (LVP) market size is predicted to grow from US$ 10990 million in 2025 to US$ 14670 million in 2031; it is expected to grow at a CAGR of 4.9% from 2025 to 2031.
Large volume parenteral preparations or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml, with the most common sizes being 250 ml, 500 ml, 1000 ml, 3000 ml and 5000 ml, with instructions usually recommending large volumes for administration. Parenteral preparations are sterile solid dosage forms or non-pyrogenic liquids containing one or more active ingredients in single-dose or multi-dose containers. They are intended to be administered by infusion, implant or injection into the body.
Global key players of Large Volume Parenteral (LVP) include Baxter Healthcare, Kelun Group, Fresenius, B. Braun, Ostuka Pharmaceutical, etc. The top five players hold a share about 68%. Asia-Pacific is the world's largest market for Large Volume Parenteral (LVP) and holds a share about xx%, followed by Europe and North America, with share about 25% and 24%, separately. In terms of product type, Soft Bag LVP is the largest segment, accounting for a share about 57%. In terms of application, Basic Infusion is the largest field with a share about 63 percent.
LP Information, Inc. (LPI) ' newest research report, the “Large Volume Parenteral (LVP) Industry Forecast” looks at past sales and reviews total world Large Volume Parenteral (LVP) sales in 2024, providing a comprehensive analysis by region and market sector of projected Large Volume Parenteral (LVP) sales for 2025 through 2031. With Large Volume Parenteral (LVP) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Large Volume Parenteral (LVP) industry.
This Insight Report provides a comprehensive analysis of the global Large Volume Parenteral (LVP) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Large Volume Parenteral (LVP) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Large Volume Parenteral (LVP) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Large Volume Parenteral (LVP) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Large Volume Parenteral (LVP).
This report presents a comprehensive overview, market shares, and growth opportunities of Large Volume Parenteral (LVP) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Soft Bag LVP
- Plastic Bottle LVP
- Glass Bottle LVP
- Basic Infusion
- Therapeutic Infusion
- Nutritious Infusion
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Baxter Healthcare
- Kelun Group
- Fresenius
- B. Braun
- Ostuka Pharmaceutical
- ICU Medical
- SSY Group
- Shuang Hor
- Cisen Pharmaceutical
- PiSA Farmacйutica
- Huaren Pharmaceutical
- Chimin
- Beximco Pharma
- Albert David
- PSI Ltd
- Ozon Pharmaceuticals
- BML Parenteral Drugs
What is the 10-year outlook for the global Large Volume Parenteral (LVP) market?
What factors are driving Large Volume Parenteral (LVP) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Large Volume Parenteral (LVP) market opportunities vary by end market size?
How does Large Volume Parenteral (LVP) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Large Volume Parenteral (LVP) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Large Volume Parenteral (LVP) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Large Volume Parenteral (LVP) by Country/Region, 2020, 2024 & 2031
2.2 Large Volume Parenteral (LVP) Segment by Type
2.2.1 Soft Bag LVP
2.2.2 Plastic Bottle LVP
2.2.3 Glass Bottle LVP
2.3 Large Volume Parenteral (LVP) Sales by Type
2.3.1 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2020-2025)
2.3.2 Global Large Volume Parenteral (LVP) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Large Volume Parenteral (LVP) Sale Price by Type (2020-2025)
2.4 Large Volume Parenteral (LVP) Segment by Application
2.4.1 Basic Infusion
2.4.2 Therapeutic Infusion
2.4.3 Nutritious Infusion
2.5 Large Volume Parenteral (LVP) Sales by Application
2.5.1 Global Large Volume Parenteral (LVP) Sale Market Share by Application (2020-2025)
2.5.2 Global Large Volume Parenteral (LVP) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Large Volume Parenteral (LVP) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Large Volume Parenteral (LVP) Breakdown Data by Company
3.1.1 Global Large Volume Parenteral (LVP) Annual Sales by Company (2020-2025)
3.1.2 Global Large Volume Parenteral (LVP) Sales Market Share by Company (2020-2025)
3.2 Global Large Volume Parenteral (LVP) Annual Revenue by Company (2020-2025)
3.2.1 Global Large Volume Parenteral (LVP) Revenue by Company (2020-2025)
3.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Company (2020-2025)
3.3 Global Large Volume Parenteral (LVP) Sale Price by Company
3.4 Key Manufacturers Large Volume Parenteral (LVP) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Large Volume Parenteral (LVP) Product Location Distribution
3.4.2 Players Large Volume Parenteral (LVP) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LARGE VOLUME PARENTERAL (LVP) BY GEOGRAPHIC REGION
4.1 World Historic Large Volume Parenteral (LVP) Market Size by Geographic Region (2020-2025)
4.1.1 Global Large Volume Parenteral (LVP) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Large Volume Parenteral (LVP) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Large Volume Parenteral (LVP) Market Size by Country/Region (2020-2025)
4.2.1 Global Large Volume Parenteral (LVP) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Large Volume Parenteral (LVP) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Large Volume Parenteral (LVP) Sales Growth
4.4 APAC Large Volume Parenteral (LVP) Sales Growth
4.5 Europe Large Volume Parenteral (LVP) Sales Growth
4.6 Middle East & Africa Large Volume Parenteral (LVP) Sales Growth
5 AMERICAS
5.1 Americas Large Volume Parenteral (LVP) Sales by Country
5.1.1 Americas Large Volume Parenteral (LVP) Sales by Country (2020-2025)
5.1.2 Americas Large Volume Parenteral (LVP) Revenue by Country (2020-2025)
5.2 Americas Large Volume Parenteral (LVP) Sales by Type (2020-2025)
5.3 Americas Large Volume Parenteral (LVP) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Large Volume Parenteral (LVP) Sales by Region
6.1.1 APAC Large Volume Parenteral (LVP) Sales by Region (2020-2025)
6.1.2 APAC Large Volume Parenteral (LVP) Revenue by Region (2020-2025)
6.2 APAC Large Volume Parenteral (LVP) Sales by Type (2020-2025)
6.3 APAC Large Volume Parenteral (LVP) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Large Volume Parenteral (LVP) by Country
7.1.1 Europe Large Volume Parenteral (LVP) Sales by Country (2020-2025)
7.1.2 Europe Large Volume Parenteral (LVP) Revenue by Country (2020-2025)
7.2 Europe Large Volume Parenteral (LVP) Sales by Type (2020-2025)
7.3 Europe Large Volume Parenteral (LVP) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Large Volume Parenteral (LVP) by Country
8.1.1 Middle East & Africa Large Volume Parenteral (LVP) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Large Volume Parenteral (LVP) Revenue by Country (2020-2025)
8.2 Middle East & Africa Large Volume Parenteral (LVP) Sales by Type (2020-2025)
8.3 Middle East & Africa Large Volume Parenteral (LVP) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Large Volume Parenteral (LVP)
10.3 Manufacturing Process Analysis of Large Volume Parenteral (LVP)
10.4 Industry Chain Structure of Large Volume Parenteral (LVP)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Large Volume Parenteral (LVP) Distributors
11.3 Large Volume Parenteral (LVP) Customer
12 WORLD FORECAST REVIEW FOR LARGE VOLUME PARENTERAL (LVP) BY GEOGRAPHIC REGION
12.1 Global Large Volume Parenteral (LVP) Market Size Forecast by Region
12.1.1 Global Large Volume Parenteral (LVP) Forecast by Region (2026-2031)
12.1.2 Global Large Volume Parenteral (LVP) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Large Volume Parenteral (LVP) Forecast by Type (2026-2031)
12.7 Global Large Volume Parenteral (LVP) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Baxter Healthcare
13.1.1 Baxter Healthcare Company Information
13.1.2 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Baxter Healthcare Main Business Overview
13.1.5 Baxter Healthcare Latest Developments
13.2 Kelun Group
13.2.1 Kelun Group Company Information
13.2.2 Kelun Group Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.2.3 Kelun Group Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Kelun Group Main Business Overview
13.2.5 Kelun Group Latest Developments
13.3 Fresenius
13.3.1 Fresenius Company Information
13.3.2 Fresenius Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.3.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Fresenius Main Business Overview
13.3.5 Fresenius Latest Developments
13.4 B. Braun
13.4.1 B. Braun Company Information
13.4.2 B. Braun Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.4.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 B. Braun Main Business Overview
13.4.5 B. Braun Latest Developments
13.5 Ostuka Pharmaceutical
13.5.1 Ostuka Pharmaceutical Company Information
13.5.2 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.5.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ostuka Pharmaceutical Main Business Overview
13.5.5 Ostuka Pharmaceutical Latest Developments
13.6 ICU Medical
13.6.1 ICU Medical Company Information
13.6.2 ICU Medical Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.6.3 ICU Medical Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 ICU Medical Main Business Overview
13.6.5 ICU Medical Latest Developments
13.7 SSY Group
13.7.1 SSY Group Company Information
13.7.2 SSY Group Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.7.3 SSY Group Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 SSY Group Main Business Overview
13.7.5 SSY Group Latest Developments
13.8 Shuang Hor
13.8.1 Shuang Hor Company Information
13.8.2 Shuang Hor Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.8.3 Shuang Hor Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Shuang Hor Main Business Overview
13.8.5 Shuang Hor Latest Developments
13.9 Cisen Pharmaceutical
13.9.1 Cisen Pharmaceutical Company Information
13.9.2 Cisen Pharmaceutical Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.9.3 Cisen Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Cisen Pharmaceutical Main Business Overview
13.9.5 Cisen Pharmaceutical Latest Developments
13.10 PiSA Farmacйutica
13.10.1 PiSA Farmacйutica Company Information
13.10.2 PiSA Farmacйutica Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.10.3 PiSA Farmacйutica Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 PiSA Farmacйutica Main Business Overview
13.10.5 PiSA Farmacйutica Latest Developments
13.11 Huaren Pharmaceutical
13.11.1 Huaren Pharmaceutical Company Information
13.11.2 Huaren Pharmaceutical Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.11.3 Huaren Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Huaren Pharmaceutical Main Business Overview
13.11.5 Huaren Pharmaceutical Latest Developments
13.12 Chimin
13.12.1 Chimin Company Information
13.12.2 Chimin Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.12.3 Chimin Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Chimin Main Business Overview
13.12.5 Chimin Latest Developments
13.13 Beximco Pharma
13.13.1 Beximco Pharma Company Information
13.13.2 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.13.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Beximco Pharma Main Business Overview
13.13.5 Beximco Pharma Latest Developments
13.14 Albert David
13.14.1 Albert David Company Information
13.14.2 Albert David Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.14.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Albert David Main Business Overview
13.14.5 Albert David Latest Developments
13.15 PSI Ltd
13.15.1 PSI Ltd Company Information
13.15.2 PSI Ltd Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.15.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 PSI Ltd Main Business Overview
13.15.5 PSI Ltd Latest Developments
13.16 Ozon Pharmaceuticals
13.16.1 Ozon Pharmaceuticals Company Information
13.16.2 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.16.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Ozon Pharmaceuticals Main Business Overview
13.16.5 Ozon Pharmaceuticals Latest Developments
13.17 BML Parenteral Drugs
13.17.1 BML Parenteral Drugs Company Information
13.17.2 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 BML Parenteral Drugs Main Business Overview
13.17.5 BML Parenteral Drugs Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Large Volume Parenteral (LVP) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Large Volume Parenteral (LVP) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Soft Bag LVP
Table 4. Major Players of Plastic Bottle LVP
Table 5. Major Players of Glass Bottle LVP
Table 6. Global Large Volume Parenteral (LVP) Sales byType (2020-2025) & (Million Units)
Table 7. Global Large Volume Parenteral (LVP) Sales Market Share byType (2020-2025)
Table 8. Global Large Volume Parenteral (LVP) Revenue byType (2020-2025) & ($ million)
Table 9. Global Large Volume Parenteral (LVP) Revenue Market Share byType (2020-2025)
Table 10. Global Large Volume Parenteral (LVP) Sale Price byType (2020-2025) & (US$/K Units)
Table 11. Global Large Volume Parenteral (LVP) Sale by Application (2020-2025) & (Million Units)
Table 12. Global Large Volume Parenteral (LVP) Sale Market Share by Application (2020-2025)
Table 13. Global Large Volume Parenteral (LVP) Revenue by Application (2020-2025) & ($ million)
Table 14. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2020-2025)
Table 15. Global Large Volume Parenteral (LVP) Sale Price by Application (2020-2025) & (US$/K Units)
Table 16. Global Large Volume Parenteral (LVP) Sales by Company (2020-2025) & (Million Units)
Table 17. Global Large Volume Parenteral (LVP) Sales Market Share by Company (2020-2025)
Table 18. Global Large Volume Parenteral (LVP) Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Large Volume Parenteral (LVP) Revenue Market Share by Company (2020-2025)
Table 20. Global Large Volume Parenteral (LVP) Sale Price by Company (2020-2025) & (US$/K Units)
Table 21. Key Manufacturers Large Volume Parenteral (LVP) Producing Area Distribution and Sales Area
Table 22. Players Large Volume Parenteral (LVP) Products Offered
Table 23. Large Volume Parenteral (LVP) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Large Volume Parenteral (LVP) Sales by Geographic Region (2020-2025) & (Million Units)
Table 27. Global Large Volume Parenteral (LVP) Sales Market Share Geographic Region (2020-2025)
Table 28. Global Large Volume Parenteral (LVP) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Large Volume Parenteral (LVP) Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Large Volume Parenteral (LVP) Sales by Country/Region (2020-2025) & (Million Units)
Table 31. Global Large Volume Parenteral (LVP) Sales Market Share by Country/Region (2020-2025)
Table 32. Global Large Volume Parenteral (LVP) Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Large Volume Parenteral (LVP) Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Large Volume Parenteral (LVP) Sales by Country (2020-2025) & (Million Units)
Table 35. Americas Large Volume Parenteral (LVP) Sales Market Share by Country (2020-2025)
Table 36. Americas Large Volume Parenteral (LVP) Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Large Volume Parenteral (LVP) Sales byType (2020-2025) & (Million Units)
Table 38. Americas Large Volume Parenteral (LVP) Sales by Application (2020-2025) & (Million Units)
Table 39. APAC Large Volume Parenteral (LVP) Sales by Region (2020-2025) & (Million Units)
Table 40. APAC Large Volume Parenteral (LVP) Sales Market Share by Region (2020-2025)
Table 41. APAC Large Volume Parenteral (LVP) Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Large Volume Parenteral (LVP) Sales byType (2020-2025) & (Million Units)
Table 43. APAC Large Volume Parenteral (LVP) Sales by Application (2020-2025) & (Million Units)
Table 44. Europe Large Volume Parenteral (LVP) Sales by Country (2020-2025) & (Million Units)
Table 45. Europe Large Volume Parenteral (LVP) Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Large Volume Parenteral (LVP) Sales byType (2020-2025) & (Million Units)
Table 47. Europe Large Volume Parenteral (LVP) Sales by Application (2020-2025) & (Million Units)
Table 48. Middle East & Africa Large Volume Parenteral (LVP) Sales by Country (2020-2025) & (Million Units)
Table 49. Middle East & Africa Large Volume Parenteral (LVP) Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Large Volume Parenteral (LVP) Sales byType (2020-2025) & (Million Units)
Table 51. Middle East & Africa Large Volume Parenteral (LVP) Sales by Application (2020-2025) & (Million Units)
Table 52. Key Market Drivers & Growth Opportunities of Large Volume Parenteral (LVP)
Table 53. Key Market Challenges & Risks of Large Volume Parenteral (LVP)
Table 54. Key IndustryTrends of Large Volume Parenteral (LVP)
Table 55. Large Volume Parenteral (LVP) Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Large Volume Parenteral (LVP) Distributors List
Table 58. Large Volume Parenteral (LVP) Customer List
Table 59. Global Large Volume Parenteral (LVP) SalesForecast by Region (2026-2031) & (Million Units)
Table 60. Global Large Volume Parenteral (LVP) RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Large Volume Parenteral (LVP) SalesForecast by Country (2026-2031) & (Million Units)
Table 62. Americas Large Volume Parenteral (LVP) Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Large Volume Parenteral (LVP) SalesForecast by Region (2026-2031) & (Million Units)
Table 64. APAC Large Volume Parenteral (LVP) Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Large Volume Parenteral (LVP) SalesForecast by Country (2026-2031) & (Million Units)
Table 66. Europe Large Volume Parenteral (LVP) RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Large Volume Parenteral (LVP) SalesForecast by Country (2026-2031) & (Million Units)
Table 68. Middle East & Africa Large Volume Parenteral (LVP) RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Large Volume Parenteral (LVP) SalesForecast byType (2026-2031) & (Million Units)
Table 70. Global Large Volume Parenteral (LVP) RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Large Volume Parenteral (LVP) SalesForecast by Application (2026-2031) & (Million Units)
Table 72. Global Large Volume Parenteral (LVP) RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Baxter Healthcare Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 74. Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 75. Baxter Healthcare Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 76. Baxter Healthcare Main Business
Table 77. Baxter Healthcare Latest Developments
Table 78. Kelun Group Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 79. Kelun Group Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 80. Kelun Group Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 81. Kelun Group Main Business
Table 82. Kelun Group Latest Developments
Table 83.Fresenius Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 84.Fresenius Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 85.Fresenius Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 86.Fresenius Main Business
Table 87.Fresenius Latest Developments
Table 88. B. Braun Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 89. B. Braun Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 90. B. Braun Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 91. B. Braun Main Business
Table 92. B. Braun Latest Developments
Table 93. Ostuka Pharmaceutical Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 94. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 95. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 96. Ostuka Pharmaceutical Main Business
Table 97. Ostuka Pharmaceutical Latest Developments
Table 98. ICU Medical Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 99. ICU Medical Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 100. ICU Medical Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 101. ICU Medical Main Business
Table 102. ICU Medical Latest Developments
Table 103. SSY Group Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 104. SSY Group Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 105. SSY Group Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 106. SSY Group Main Business
Table 107. SSY Group Latest Developments
Table 108. Shuang Hor Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 109. Shuang Hor Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 110. Shuang Hor Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 111. Shuang Hor Main Business
Table 112. Shuang Hor Latest Developments
Table 113. Cisen Pharmaceutical Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 114. Cisen Pharmaceutical Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 115. Cisen Pharmaceutical Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 116. Cisen Pharmaceutical Main Business
Table 117. Cisen Pharmaceutical Latest Developments
Table 118. PiSAFarmacйutica Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 119. PiSAFarmacйutica Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 120. PiSAFarmacйutica Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 121. PiSAFarmacйutica Main Business
Table 122. PiSAFarmacйutica Latest Developments
Table 123. Huaren Pharmaceutical Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 124. Huaren Pharmaceutical Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 125. Huaren Pharmaceutical Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 126. Huaren Pharmaceutical Main Business
Table 127. Huaren Pharmaceutical Latest Developments
Table 128. Chimin Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 129. Chimin Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 130. Chimin Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 131. Chimin Main Business
Table 132. Chimin Latest Developments
Table 133. Beximco Pharma Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 134. Beximco Pharma Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 135. Beximco Pharma Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 136. Beximco Pharma Main Business
Table 137. Beximco Pharma Latest Developments
Table 138. Albert David Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 139. Albert David Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 140. Albert David Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 141. Albert David Main Business
Table 142. Albert David Latest Developments
Table 143. PSI Ltd Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 144. PSI Ltd Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 145. PSI Ltd Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 146. PSI Ltd Main Business
Table 147. PSI Ltd Latest Developments
Table 148. Ozon Pharmaceuticals Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 149. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 150. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 151. Ozon Pharmaceuticals Main Business
Table 152. Ozon Pharmaceuticals Latest Developments
Table 153. BML Parenteral Drugs Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 154. BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 155. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 156. BML Parenteral Drugs Main Business
Table 157. BML Parenteral Drugs Latest Developments
LIST OFFIGURES
Figure 1. Picture of Large Volume Parenteral (LVP)
Figure 2. Large Volume Parenteral (LVP) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Large Volume Parenteral (LVP) Sales Growth Rate 2020-2031 (Million Units)
Figure 7. Global Large Volume Parenteral (LVP) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Large Volume Parenteral (LVP) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Large Volume Parenteral (LVP) Sales Market Share by Country/Region (2024)
Figure 10. Large Volume Parenteral (LVP) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Soft Bag LVP
Figure 12. Product Picture of Plastic Bottle LVP
Figure 13. Product Picture of Glass Bottle LVP
Figure 14. Global Large Volume Parenteral (LVP) Sales Market Share byType in 2025
Figure 15. Global Large Volume Parenteral (LVP) Revenue Market Share byType (2020-2025)
Figure 16. Large Volume Parenteral (LVP) Consumed in Basic Infusion
Figure 17. Global Large Volume Parenteral (LVP) Market: Basic Infusion (2020-2025) & (Million Units)
Figure 18. Large Volume Parenteral (LVP) Consumed inTherapeutic Infusion
Figure 19. Global Large Volume Parenteral (LVP) Market:Therapeutic Infusion (2020-2025) & (Million Units)
Figure 20. Large Volume Parenteral (LVP) Consumed in Nutritious Infusion
Figure 21. Global Large Volume Parenteral (LVP) Market: Nutritious Infusion (2020-2025) & (Million Units)
Figure 22. Global Large Volume Parenteral (LVP) Sale Market Share by Application (2024)
Figure 23. Global Large Volume Parenteral (LVP) Revenue Market Share by Application in 2025
Figure 24. Large Volume Parenteral (LVP) Sales by Company in 2025 (Million Units)
Figure 25. Global Large Volume Parenteral (LVP) Sales Market Share by Company in 2025
Figure 26. Large Volume Parenteral (LVP) Revenue by Company in 2025 ($ millions)
Figure 27. Global Large Volume Parenteral (LVP) Revenue Market Share by Company in 2025
Figure 28. Global Large Volume Parenteral (LVP) Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Large Volume Parenteral (LVP) Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Large Volume Parenteral (LVP) Sales 2020-2025 (Million Units)
Figure 31. Americas Large Volume Parenteral (LVP) Revenue 2020-2025 ($ millions)
Figure 32. APAC Large Volume Parenteral (LVP) Sales 2020-2025 (Million Units)
Figure 33. APAC Large Volume Parenteral (LVP) Revenue 2020-2025 ($ millions)
Figure 34. Europe Large Volume Parenteral (LVP) Sales 2020-2025 (Million Units)
Figure 35. Europe Large Volume Parenteral (LVP) Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Large Volume Parenteral (LVP) Sales 2020-2025 (Million Units)
Figure 37. Middle East & Africa Large Volume Parenteral (LVP) Revenue 2020-2025 ($ millions)
Figure 38. Americas Large Volume Parenteral (LVP) Sales Market Share by Country in 2025
Figure 39. Americas Large Volume Parenteral (LVP) Revenue Market Share by Country (2020-2025)
Figure 40. Americas Large Volume Parenteral (LVP) Sales Market Share byType (2020-2025)
Figure 41. Americas Large Volume Parenteral (LVP) Sales Market Share by Application (2020-2025)
Figure 42. United States Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Large Volume Parenteral (LVP) Sales Market Share by Region in 2025
Figure 47. APAC Large Volume Parenteral (LVP) Revenue Market Share by Region (2020-2025)
Figure 48. APAC Large Volume Parenteral (LVP) Sales Market Share byType (2020-2025)
Figure 49. APAC Large Volume Parenteral (LVP) Sales Market Share by Application (2020-2025)
Figure 50. China Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 54. India Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Large Volume Parenteral (LVP) Sales Market Share by Country in 2025
Figure 58. Europe Large Volume Parenteral (LVP) Revenue Market Share by Country (2020-2025)
Figure 59. Europe Large Volume Parenteral (LVP) Sales Market Share byType (2020-2025)
Figure 60. Europe Large Volume Parenteral (LVP) Sales Market Share by Application (2020-2025)
Figure 61. Germany Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 62.France Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Large Volume Parenteral (LVP) Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Large Volume Parenteral (LVP) Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Large Volume Parenteral (LVP) Sales Market Share by Application (2020-2025)
Figure 69. Egypt Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Large Volume Parenteral (LVP) in 2025
Figure 75. Manufacturing Process Analysis of Large Volume Parenteral (LVP)
Figure 76. Industry Chain Structure of Large Volume Parenteral (LVP)
Figure 77. Channels of Distribution
Figure 78. Global Large Volume Parenteral (LVP) Sales MarketForecast by Region (2026-2031)
Figure 79. Global Large Volume Parenteral (LVP) Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Large Volume Parenteral (LVP) Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Large Volume Parenteral (LVP) Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Large Volume Parenteral (LVP) Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Large Volume Parenteral (LVP) Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Large Volume Parenteral (LVP) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Large Volume Parenteral (LVP) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Large Volume Parenteral (LVP) by Country/Region, 2020, 2024 & 2031
2.2 Large Volume Parenteral (LVP) Segment by Type
2.2.1 Soft Bag LVP
2.2.2 Plastic Bottle LVP
2.2.3 Glass Bottle LVP
2.3 Large Volume Parenteral (LVP) Sales by Type
2.3.1 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2020-2025)
2.3.2 Global Large Volume Parenteral (LVP) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Large Volume Parenteral (LVP) Sale Price by Type (2020-2025)
2.4 Large Volume Parenteral (LVP) Segment by Application
2.4.1 Basic Infusion
2.4.2 Therapeutic Infusion
2.4.3 Nutritious Infusion
2.5 Large Volume Parenteral (LVP) Sales by Application
2.5.1 Global Large Volume Parenteral (LVP) Sale Market Share by Application (2020-2025)
2.5.2 Global Large Volume Parenteral (LVP) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Large Volume Parenteral (LVP) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Large Volume Parenteral (LVP) Breakdown Data by Company
3.1.1 Global Large Volume Parenteral (LVP) Annual Sales by Company (2020-2025)
3.1.2 Global Large Volume Parenteral (LVP) Sales Market Share by Company (2020-2025)
3.2 Global Large Volume Parenteral (LVP) Annual Revenue by Company (2020-2025)
3.2.1 Global Large Volume Parenteral (LVP) Revenue by Company (2020-2025)
3.2.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Company (2020-2025)
3.3 Global Large Volume Parenteral (LVP) Sale Price by Company
3.4 Key Manufacturers Large Volume Parenteral (LVP) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Large Volume Parenteral (LVP) Product Location Distribution
3.4.2 Players Large Volume Parenteral (LVP) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LARGE VOLUME PARENTERAL (LVP) BY GEOGRAPHIC REGION
4.1 World Historic Large Volume Parenteral (LVP) Market Size by Geographic Region (2020-2025)
4.1.1 Global Large Volume Parenteral (LVP) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Large Volume Parenteral (LVP) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Large Volume Parenteral (LVP) Market Size by Country/Region (2020-2025)
4.2.1 Global Large Volume Parenteral (LVP) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Large Volume Parenteral (LVP) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Large Volume Parenteral (LVP) Sales Growth
4.4 APAC Large Volume Parenteral (LVP) Sales Growth
4.5 Europe Large Volume Parenteral (LVP) Sales Growth
4.6 Middle East & Africa Large Volume Parenteral (LVP) Sales Growth
5 AMERICAS
5.1 Americas Large Volume Parenteral (LVP) Sales by Country
5.1.1 Americas Large Volume Parenteral (LVP) Sales by Country (2020-2025)
5.1.2 Americas Large Volume Parenteral (LVP) Revenue by Country (2020-2025)
5.2 Americas Large Volume Parenteral (LVP) Sales by Type (2020-2025)
5.3 Americas Large Volume Parenteral (LVP) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Large Volume Parenteral (LVP) Sales by Region
6.1.1 APAC Large Volume Parenteral (LVP) Sales by Region (2020-2025)
6.1.2 APAC Large Volume Parenteral (LVP) Revenue by Region (2020-2025)
6.2 APAC Large Volume Parenteral (LVP) Sales by Type (2020-2025)
6.3 APAC Large Volume Parenteral (LVP) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Large Volume Parenteral (LVP) by Country
7.1.1 Europe Large Volume Parenteral (LVP) Sales by Country (2020-2025)
7.1.2 Europe Large Volume Parenteral (LVP) Revenue by Country (2020-2025)
7.2 Europe Large Volume Parenteral (LVP) Sales by Type (2020-2025)
7.3 Europe Large Volume Parenteral (LVP) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Large Volume Parenteral (LVP) by Country
8.1.1 Middle East & Africa Large Volume Parenteral (LVP) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Large Volume Parenteral (LVP) Revenue by Country (2020-2025)
8.2 Middle East & Africa Large Volume Parenteral (LVP) Sales by Type (2020-2025)
8.3 Middle East & Africa Large Volume Parenteral (LVP) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Large Volume Parenteral (LVP)
10.3 Manufacturing Process Analysis of Large Volume Parenteral (LVP)
10.4 Industry Chain Structure of Large Volume Parenteral (LVP)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Large Volume Parenteral (LVP) Distributors
11.3 Large Volume Parenteral (LVP) Customer
12 WORLD FORECAST REVIEW FOR LARGE VOLUME PARENTERAL (LVP) BY GEOGRAPHIC REGION
12.1 Global Large Volume Parenteral (LVP) Market Size Forecast by Region
12.1.1 Global Large Volume Parenteral (LVP) Forecast by Region (2026-2031)
12.1.2 Global Large Volume Parenteral (LVP) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Large Volume Parenteral (LVP) Forecast by Type (2026-2031)
12.7 Global Large Volume Parenteral (LVP) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Baxter Healthcare
13.1.1 Baxter Healthcare Company Information
13.1.2 Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Baxter Healthcare Main Business Overview
13.1.5 Baxter Healthcare Latest Developments
13.2 Kelun Group
13.2.1 Kelun Group Company Information
13.2.2 Kelun Group Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.2.3 Kelun Group Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Kelun Group Main Business Overview
13.2.5 Kelun Group Latest Developments
13.3 Fresenius
13.3.1 Fresenius Company Information
13.3.2 Fresenius Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.3.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Fresenius Main Business Overview
13.3.5 Fresenius Latest Developments
13.4 B. Braun
13.4.1 B. Braun Company Information
13.4.2 B. Braun Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.4.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 B. Braun Main Business Overview
13.4.5 B. Braun Latest Developments
13.5 Ostuka Pharmaceutical
13.5.1 Ostuka Pharmaceutical Company Information
13.5.2 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.5.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ostuka Pharmaceutical Main Business Overview
13.5.5 Ostuka Pharmaceutical Latest Developments
13.6 ICU Medical
13.6.1 ICU Medical Company Information
13.6.2 ICU Medical Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.6.3 ICU Medical Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 ICU Medical Main Business Overview
13.6.5 ICU Medical Latest Developments
13.7 SSY Group
13.7.1 SSY Group Company Information
13.7.2 SSY Group Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.7.3 SSY Group Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 SSY Group Main Business Overview
13.7.5 SSY Group Latest Developments
13.8 Shuang Hor
13.8.1 Shuang Hor Company Information
13.8.2 Shuang Hor Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.8.3 Shuang Hor Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Shuang Hor Main Business Overview
13.8.5 Shuang Hor Latest Developments
13.9 Cisen Pharmaceutical
13.9.1 Cisen Pharmaceutical Company Information
13.9.2 Cisen Pharmaceutical Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.9.3 Cisen Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Cisen Pharmaceutical Main Business Overview
13.9.5 Cisen Pharmaceutical Latest Developments
13.10 PiSA Farmacйutica
13.10.1 PiSA Farmacйutica Company Information
13.10.2 PiSA Farmacйutica Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.10.3 PiSA Farmacйutica Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 PiSA Farmacйutica Main Business Overview
13.10.5 PiSA Farmacйutica Latest Developments
13.11 Huaren Pharmaceutical
13.11.1 Huaren Pharmaceutical Company Information
13.11.2 Huaren Pharmaceutical Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.11.3 Huaren Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Huaren Pharmaceutical Main Business Overview
13.11.5 Huaren Pharmaceutical Latest Developments
13.12 Chimin
13.12.1 Chimin Company Information
13.12.2 Chimin Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.12.3 Chimin Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Chimin Main Business Overview
13.12.5 Chimin Latest Developments
13.13 Beximco Pharma
13.13.1 Beximco Pharma Company Information
13.13.2 Beximco Pharma Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.13.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Beximco Pharma Main Business Overview
13.13.5 Beximco Pharma Latest Developments
13.14 Albert David
13.14.1 Albert David Company Information
13.14.2 Albert David Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.14.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Albert David Main Business Overview
13.14.5 Albert David Latest Developments
13.15 PSI Ltd
13.15.1 PSI Ltd Company Information
13.15.2 PSI Ltd Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.15.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 PSI Ltd Main Business Overview
13.15.5 PSI Ltd Latest Developments
13.16 Ozon Pharmaceuticals
13.16.1 Ozon Pharmaceuticals Company Information
13.16.2 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.16.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Ozon Pharmaceuticals Main Business Overview
13.16.5 Ozon Pharmaceuticals Latest Developments
13.17 BML Parenteral Drugs
13.17.1 BML Parenteral Drugs Company Information
13.17.2 BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolios and Specifications
13.17.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 BML Parenteral Drugs Main Business Overview
13.17.5 BML Parenteral Drugs Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Large Volume Parenteral (LVP) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Large Volume Parenteral (LVP) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Soft Bag LVP
Table 4. Major Players of Plastic Bottle LVP
Table 5. Major Players of Glass Bottle LVP
Table 6. Global Large Volume Parenteral (LVP) Sales byType (2020-2025) & (Million Units)
Table 7. Global Large Volume Parenteral (LVP) Sales Market Share byType (2020-2025)
Table 8. Global Large Volume Parenteral (LVP) Revenue byType (2020-2025) & ($ million)
Table 9. Global Large Volume Parenteral (LVP) Revenue Market Share byType (2020-2025)
Table 10. Global Large Volume Parenteral (LVP) Sale Price byType (2020-2025) & (US$/K Units)
Table 11. Global Large Volume Parenteral (LVP) Sale by Application (2020-2025) & (Million Units)
Table 12. Global Large Volume Parenteral (LVP) Sale Market Share by Application (2020-2025)
Table 13. Global Large Volume Parenteral (LVP) Revenue by Application (2020-2025) & ($ million)
Table 14. Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2020-2025)
Table 15. Global Large Volume Parenteral (LVP) Sale Price by Application (2020-2025) & (US$/K Units)
Table 16. Global Large Volume Parenteral (LVP) Sales by Company (2020-2025) & (Million Units)
Table 17. Global Large Volume Parenteral (LVP) Sales Market Share by Company (2020-2025)
Table 18. Global Large Volume Parenteral (LVP) Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Large Volume Parenteral (LVP) Revenue Market Share by Company (2020-2025)
Table 20. Global Large Volume Parenteral (LVP) Sale Price by Company (2020-2025) & (US$/K Units)
Table 21. Key Manufacturers Large Volume Parenteral (LVP) Producing Area Distribution and Sales Area
Table 22. Players Large Volume Parenteral (LVP) Products Offered
Table 23. Large Volume Parenteral (LVP) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Large Volume Parenteral (LVP) Sales by Geographic Region (2020-2025) & (Million Units)
Table 27. Global Large Volume Parenteral (LVP) Sales Market Share Geographic Region (2020-2025)
Table 28. Global Large Volume Parenteral (LVP) Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Large Volume Parenteral (LVP) Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Large Volume Parenteral (LVP) Sales by Country/Region (2020-2025) & (Million Units)
Table 31. Global Large Volume Parenteral (LVP) Sales Market Share by Country/Region (2020-2025)
Table 32. Global Large Volume Parenteral (LVP) Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Large Volume Parenteral (LVP) Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Large Volume Parenteral (LVP) Sales by Country (2020-2025) & (Million Units)
Table 35. Americas Large Volume Parenteral (LVP) Sales Market Share by Country (2020-2025)
Table 36. Americas Large Volume Parenteral (LVP) Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Large Volume Parenteral (LVP) Sales byType (2020-2025) & (Million Units)
Table 38. Americas Large Volume Parenteral (LVP) Sales by Application (2020-2025) & (Million Units)
Table 39. APAC Large Volume Parenteral (LVP) Sales by Region (2020-2025) & (Million Units)
Table 40. APAC Large Volume Parenteral (LVP) Sales Market Share by Region (2020-2025)
Table 41. APAC Large Volume Parenteral (LVP) Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Large Volume Parenteral (LVP) Sales byType (2020-2025) & (Million Units)
Table 43. APAC Large Volume Parenteral (LVP) Sales by Application (2020-2025) & (Million Units)
Table 44. Europe Large Volume Parenteral (LVP) Sales by Country (2020-2025) & (Million Units)
Table 45. Europe Large Volume Parenteral (LVP) Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Large Volume Parenteral (LVP) Sales byType (2020-2025) & (Million Units)
Table 47. Europe Large Volume Parenteral (LVP) Sales by Application (2020-2025) & (Million Units)
Table 48. Middle East & Africa Large Volume Parenteral (LVP) Sales by Country (2020-2025) & (Million Units)
Table 49. Middle East & Africa Large Volume Parenteral (LVP) Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Large Volume Parenteral (LVP) Sales byType (2020-2025) & (Million Units)
Table 51. Middle East & Africa Large Volume Parenteral (LVP) Sales by Application (2020-2025) & (Million Units)
Table 52. Key Market Drivers & Growth Opportunities of Large Volume Parenteral (LVP)
Table 53. Key Market Challenges & Risks of Large Volume Parenteral (LVP)
Table 54. Key IndustryTrends of Large Volume Parenteral (LVP)
Table 55. Large Volume Parenteral (LVP) Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Large Volume Parenteral (LVP) Distributors List
Table 58. Large Volume Parenteral (LVP) Customer List
Table 59. Global Large Volume Parenteral (LVP) SalesForecast by Region (2026-2031) & (Million Units)
Table 60. Global Large Volume Parenteral (LVP) RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Large Volume Parenteral (LVP) SalesForecast by Country (2026-2031) & (Million Units)
Table 62. Americas Large Volume Parenteral (LVP) Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Large Volume Parenteral (LVP) SalesForecast by Region (2026-2031) & (Million Units)
Table 64. APAC Large Volume Parenteral (LVP) Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Large Volume Parenteral (LVP) SalesForecast by Country (2026-2031) & (Million Units)
Table 66. Europe Large Volume Parenteral (LVP) RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Large Volume Parenteral (LVP) SalesForecast by Country (2026-2031) & (Million Units)
Table 68. Middle East & Africa Large Volume Parenteral (LVP) RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Large Volume Parenteral (LVP) SalesForecast byType (2026-2031) & (Million Units)
Table 70. Global Large Volume Parenteral (LVP) RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Large Volume Parenteral (LVP) SalesForecast by Application (2026-2031) & (Million Units)
Table 72. Global Large Volume Parenteral (LVP) RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Baxter Healthcare Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 74. Baxter Healthcare Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 75. Baxter Healthcare Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 76. Baxter Healthcare Main Business
Table 77. Baxter Healthcare Latest Developments
Table 78. Kelun Group Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 79. Kelun Group Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 80. Kelun Group Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 81. Kelun Group Main Business
Table 82. Kelun Group Latest Developments
Table 83.Fresenius Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 84.Fresenius Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 85.Fresenius Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 86.Fresenius Main Business
Table 87.Fresenius Latest Developments
Table 88. B. Braun Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 89. B. Braun Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 90. B. Braun Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 91. B. Braun Main Business
Table 92. B. Braun Latest Developments
Table 93. Ostuka Pharmaceutical Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 94. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 95. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 96. Ostuka Pharmaceutical Main Business
Table 97. Ostuka Pharmaceutical Latest Developments
Table 98. ICU Medical Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 99. ICU Medical Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 100. ICU Medical Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 101. ICU Medical Main Business
Table 102. ICU Medical Latest Developments
Table 103. SSY Group Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 104. SSY Group Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 105. SSY Group Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 106. SSY Group Main Business
Table 107. SSY Group Latest Developments
Table 108. Shuang Hor Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 109. Shuang Hor Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 110. Shuang Hor Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 111. Shuang Hor Main Business
Table 112. Shuang Hor Latest Developments
Table 113. Cisen Pharmaceutical Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 114. Cisen Pharmaceutical Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 115. Cisen Pharmaceutical Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 116. Cisen Pharmaceutical Main Business
Table 117. Cisen Pharmaceutical Latest Developments
Table 118. PiSAFarmacйutica Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 119. PiSAFarmacйutica Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 120. PiSAFarmacйutica Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 121. PiSAFarmacйutica Main Business
Table 122. PiSAFarmacйutica Latest Developments
Table 123. Huaren Pharmaceutical Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 124. Huaren Pharmaceutical Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 125. Huaren Pharmaceutical Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 126. Huaren Pharmaceutical Main Business
Table 127. Huaren Pharmaceutical Latest Developments
Table 128. Chimin Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 129. Chimin Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 130. Chimin Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 131. Chimin Main Business
Table 132. Chimin Latest Developments
Table 133. Beximco Pharma Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 134. Beximco Pharma Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 135. Beximco Pharma Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 136. Beximco Pharma Main Business
Table 137. Beximco Pharma Latest Developments
Table 138. Albert David Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 139. Albert David Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 140. Albert David Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 141. Albert David Main Business
Table 142. Albert David Latest Developments
Table 143. PSI Ltd Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 144. PSI Ltd Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 145. PSI Ltd Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 146. PSI Ltd Main Business
Table 147. PSI Ltd Latest Developments
Table 148. Ozon Pharmaceuticals Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 149. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 150. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 151. Ozon Pharmaceuticals Main Business
Table 152. Ozon Pharmaceuticals Latest Developments
Table 153. BML Parenteral Drugs Basic Information, Large Volume Parenteral (LVP) Manufacturing Base, Sales Area and Its Competitors
Table 154. BML Parenteral Drugs Large Volume Parenteral (LVP) Product Portfolios and Specifications
Table 155. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2025)
Table 156. BML Parenteral Drugs Main Business
Table 157. BML Parenteral Drugs Latest Developments
LIST OFFIGURES
Figure 1. Picture of Large Volume Parenteral (LVP)
Figure 2. Large Volume Parenteral (LVP) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Large Volume Parenteral (LVP) Sales Growth Rate 2020-2031 (Million Units)
Figure 7. Global Large Volume Parenteral (LVP) Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Large Volume Parenteral (LVP) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Large Volume Parenteral (LVP) Sales Market Share by Country/Region (2024)
Figure 10. Large Volume Parenteral (LVP) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Soft Bag LVP
Figure 12. Product Picture of Plastic Bottle LVP
Figure 13. Product Picture of Glass Bottle LVP
Figure 14. Global Large Volume Parenteral (LVP) Sales Market Share byType in 2025
Figure 15. Global Large Volume Parenteral (LVP) Revenue Market Share byType (2020-2025)
Figure 16. Large Volume Parenteral (LVP) Consumed in Basic Infusion
Figure 17. Global Large Volume Parenteral (LVP) Market: Basic Infusion (2020-2025) & (Million Units)
Figure 18. Large Volume Parenteral (LVP) Consumed inTherapeutic Infusion
Figure 19. Global Large Volume Parenteral (LVP) Market:Therapeutic Infusion (2020-2025) & (Million Units)
Figure 20. Large Volume Parenteral (LVP) Consumed in Nutritious Infusion
Figure 21. Global Large Volume Parenteral (LVP) Market: Nutritious Infusion (2020-2025) & (Million Units)
Figure 22. Global Large Volume Parenteral (LVP) Sale Market Share by Application (2024)
Figure 23. Global Large Volume Parenteral (LVP) Revenue Market Share by Application in 2025
Figure 24. Large Volume Parenteral (LVP) Sales by Company in 2025 (Million Units)
Figure 25. Global Large Volume Parenteral (LVP) Sales Market Share by Company in 2025
Figure 26. Large Volume Parenteral (LVP) Revenue by Company in 2025 ($ millions)
Figure 27. Global Large Volume Parenteral (LVP) Revenue Market Share by Company in 2025
Figure 28. Global Large Volume Parenteral (LVP) Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Large Volume Parenteral (LVP) Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Large Volume Parenteral (LVP) Sales 2020-2025 (Million Units)
Figure 31. Americas Large Volume Parenteral (LVP) Revenue 2020-2025 ($ millions)
Figure 32. APAC Large Volume Parenteral (LVP) Sales 2020-2025 (Million Units)
Figure 33. APAC Large Volume Parenteral (LVP) Revenue 2020-2025 ($ millions)
Figure 34. Europe Large Volume Parenteral (LVP) Sales 2020-2025 (Million Units)
Figure 35. Europe Large Volume Parenteral (LVP) Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Large Volume Parenteral (LVP) Sales 2020-2025 (Million Units)
Figure 37. Middle East & Africa Large Volume Parenteral (LVP) Revenue 2020-2025 ($ millions)
Figure 38. Americas Large Volume Parenteral (LVP) Sales Market Share by Country in 2025
Figure 39. Americas Large Volume Parenteral (LVP) Revenue Market Share by Country (2020-2025)
Figure 40. Americas Large Volume Parenteral (LVP) Sales Market Share byType (2020-2025)
Figure 41. Americas Large Volume Parenteral (LVP) Sales Market Share by Application (2020-2025)
Figure 42. United States Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Large Volume Parenteral (LVP) Sales Market Share by Region in 2025
Figure 47. APAC Large Volume Parenteral (LVP) Revenue Market Share by Region (2020-2025)
Figure 48. APAC Large Volume Parenteral (LVP) Sales Market Share byType (2020-2025)
Figure 49. APAC Large Volume Parenteral (LVP) Sales Market Share by Application (2020-2025)
Figure 50. China Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 54. India Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Large Volume Parenteral (LVP) Sales Market Share by Country in 2025
Figure 58. Europe Large Volume Parenteral (LVP) Revenue Market Share by Country (2020-2025)
Figure 59. Europe Large Volume Parenteral (LVP) Sales Market Share byType (2020-2025)
Figure 60. Europe Large Volume Parenteral (LVP) Sales Market Share by Application (2020-2025)
Figure 61. Germany Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 62.France Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Large Volume Parenteral (LVP) Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Large Volume Parenteral (LVP) Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Large Volume Parenteral (LVP) Sales Market Share by Application (2020-2025)
Figure 69. Egypt Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Large Volume Parenteral (LVP) Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Large Volume Parenteral (LVP) in 2025
Figure 75. Manufacturing Process Analysis of Large Volume Parenteral (LVP)
Figure 76. Industry Chain Structure of Large Volume Parenteral (LVP)
Figure 77. Channels of Distribution
Figure 78. Global Large Volume Parenteral (LVP) Sales MarketForecast by Region (2026-2031)
Figure 79. Global Large Volume Parenteral (LVP) Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Large Volume Parenteral (LVP) Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Large Volume Parenteral (LVP) Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Large Volume Parenteral (LVP) Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Large Volume Parenteral (LVP) Revenue Market ShareForecast by Application (2026-2031)
